Skip to main content
Drug bottle and Pill

Compare Gemtesa vs. Myrbetriq

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Vibegron (Gemtesa) and mirabegron (Myrbetriq) are both medications used to treat overactive bladder (OAB) in adults, and they belong to the same drug class, beta-3 adrenergic agonists. However, they have some differences. Vibegron is only approved for adults, while mirabegron can also be used in children ages 3 years and older for neurogenic detrusor overactivity (NDO). Vibegron is taken as a 75 mg tablet once daily, whereas mirabegron is available in tablet form and as as an oral liquid solution, with dosing that can vary based on age and condition. Neither medication has a generic version available. Common side effects of vibegron include headache and cold symptoms, while mirabegron can cause high blood pressure and urinary tract infections. Additionally, mirabegron may interact with other medications like digoxin (Lanoxin) and warfarin (Coumadin, Jantoven), while vibegron is only known to interact with digoxin. Both medications can cause angioedema, a serious allergic reaction, but mirabegron has a specific warning about raising blood pressure.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.